Summary
Updated Aug 31, 2026
John William Wulf is Director of agilon health, inc. (AGL). 3 SEC Form 4 filings on record going back to 2024, most recently on 5 June 2026. Most recent open-market trade: bought $51K of AGL on 31 January 2026. Lifetime open-market purchases: $149K.
Recent Transactions
3Every recent SEC Form 4 transaction John William Wulf has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies John William Wulf files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Benjamin Shaker - $301K of AGL open-market activity in the last 12 months
- Denise Zamore - of AGL open-market activity in the last 12 months
- Girish Venkatachaliah - of AGL open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is John William Wulf?
John William Wulf is a corporate insider, tracked as Director of agilon health, inc. (AGL). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John William Wulf submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has John William Wulf been buying or selling stock?
Recorded transactions: 2 open-market purchases ($149K) and 0 open-market sales across all tracked filings.
Where can I see all of John William Wulf's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow John William Wulf and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
